IL6 and breast carcinoma: Its role in breast cancer growth and bone metastasis was confirmed by evaluating blood samples from healthy, breast cancer, or metastatic breast cancer patients, where the higher levels of IL-6 were detected in patients with metastatic bone disease [49,50].